| Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
G | 0.700 | CausalMutation | CLINVAR | The PI3K pathway as drug target in human cancer. | 20085938 | 2010 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | The PI3K pathway as drug target in human cancer. | 20085938 | 2010 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | The PI3K pathway as drug target in human cancer. | 20085938 | 2010 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | PTEN and the PI3-kinase pathway in cancer. | 18767981 | 2009 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | PTEN and the PI3-kinase pathway in cancer. | 18767981 | 2009 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | PTEN and the PI3-kinase pathway in cancer. | 18767981 | 2009 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. | 11504908 | 2001 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. | 11504908 | 2001 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. | 11504908 | 2001 |
|||
|
A | 0.700 | GeneticVariation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
T | 0.700 | CausalMutation | CLINVAR | ||||||
|
A | 0.700 | GeneticVariation | CLINVAR | ||||||
|
T | 0.700 | CausalMutation | CLINVAR | ||||||
|
T | 0.700 | GeneticVariation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
AG | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
0.700 | CausalMutation | CLINVAR | |||||||
|
ATT | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | GeneticVariation | CLINVAR | ||||||
|
T | 0.700 | GeneticVariation | CLINVAR |